Skip to content
Search

Latest Stories

Sally Warren departs the King's Fund to join DHSC

Sally Warren departs the King's Fund to join DHSC
As Sally Warren transitions to a senior role at DHSC focusing on the ten-year health plan and NHSE collaboration, the King’s Fund initiates recruitment for a new Director of Policy to uphold its leadership in health policy

In a significant move impacting the landscape of health policy, Director of Policy at The King's Fund, Sally Warren, has announced her departure to assume a crucial role at the Department of Health and Social Care (DHSC).

This pivotal shift in Warren's role at DHSC is aimed at developing the department's ten-year health plan and close collaboration with both NHS England and DHSC.


Having joined The King’s Fund in 2019, Warren has played a central role in shaping the organization’s Policy, Events, and Partnerships Directorate.

Effective immediately, she transitions to her new responsibilities within DHSC this week.

Chief Executive of The King’s Fund, Sarah Woolnough, commended Warren’s achievements, stating, "All of us at The King’s Fund offer huge congratulations to Sally for securing such an important role at a critical time for health and care in this country."

Woolnough highlighted Warren’s substantial contributions to informing national discourse and expressed optimism about continued collaboration under her new governmental capacity.

Reflecting on her tenure, Warren remarked, "It has been a fantastic five years at The King’s Fund and an absolute privilege to work alongside such insightful, expert, and committed colleagues."

Emphasising the challenges and opportunities facing health and care services, Warren expressed eagerness to leverage her new role to drive positive change and innovation across the sector.

Following Warren’s departure, The King’s Fund is preparing for leadership continuity.

Sarah Woolnough announced, "I am delighted to announce that Chief Analyst Siva Anandaciva and Assistant Director of Policy Alex Baylis will step up as our Interim Co-Directors of Policy."

The organisation is also launching the recruitment process for a permanent Director of Policy to uphold its mission of pioneering policy development and advancing health and care improvements.

Warren’s transition underscores the dynamic interplay between policy research institutions and governmental bodies.

It underscores a commitment to addressing pressing health challenges through collaborative leadership and innovative policymaking.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less